Expression of CD34 and CD31 in Central and Peripheral Giant Cell Granulomas

Sadri, Donia; Shahsavari, Fatemeh; Hezarkhani, Maliheh; Shafizadeh, Maryam

doi:10.30476/dentjods.2019.44557

Document Type : Original Article

Authors

Dept. of Oral and Maxillofacial Pathology, Dental Branch of Tehran, Islamic Azad University, Tehran, Iran.

https://doi.org/10.30476/dentjods.2019.44557

Abstract

Statement of the Problem: Considering the clinical differences between central giant cell granulomas (CGCGs) and peripheral giant cell granulomas (CGCGs) despite their same microscopic feature and possible role of angiogenesis in this issue, Purpose: The aim of the present study was to compare microvessel density (MVD) between CGCGs and PGCGs of the oral cavity using CD31 and CD34.Materials and Method: Immunohistochemical staining was performed on 18 PGCGs and 19 CGCGs using a monoclonal antibody against CD34 and CD31. MVD was assessed and compared between the lesions using T-test for statistical analysis. p < 0.05 was considered significant.Results: The expression levels of both CD34 and CD31 were significantly higher in CGCGs compared to PGCGs (p < 0.002 and p < 0.001, respectively). Significant differences in MVD assessed by both markers were observed between males and females in PGCGs (p < 0.05), but not CGCGs (p < 0.2).Conclusion: The combined evaluation of old- and newly-formed vessels by pan-endothelial cell markers showed differences between CGCGs and PGCGs, supporting the possible vascular-proliferative nature of the former. Whether this difference has a part in their diverse biologic behaviors and the role which pre-existent vessels play in comparison to neo-formed vasculature, requires further investigation.

Keywords

References

1. Etemad-Moghadam S, Baghaee F, Dadafarid Z, Alaeddini M. A 44-year analysis of ghost cell odontogenic tumour subtypes in an Iranian population. J Craniomaxillofac Surg. 2014; 42: 1154–1159. [PubMed] [Google Scholar]

2. Flórez-Moreno GA, Henao-Ruiz M, Santa-Sáenz DM, Castañeda-Peláez DA, Tobón-Arroyave SI. Cytomorphometric and immunohistochemical comparison between central and peripheral giant cell lesions of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 625–632. [PubMed] [Google Scholar]

3. Sadri D, Hejazi M, Jahanbani J, Forouzandeh A. Quantitative analysis of argyrophilic nuclear organizer regions in giant cell lesions of jaws. J Oral Pathol Med. 2010; 39: 431–434. [PubMed] [Google Scholar]

4. Matos FR, Nonaka CF, Miguel MC, Galvão HC, de Souza LB, Freitas Rde A. Immunoexpression of MMP-9, VEGF, and vWF in central and peripheral giant cell lesions of the jaws. J Oral Pathol Med. 2011; 40: 338–344. [PubMed] [Google Scholar]

5. Souza PE, Mesquita RA, Gomez RS. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oralperipheral and central giant cell lesions. Oral Dis. 2000; 6: 35–39. [PubMed] [Google Scholar]

6. Shahsavari F, Sadri D, Miri H. Does Peripheral and Central Giant Cell Granuloma Express Different Profile of Ki67 and P27? . Adv Biores. 2016;7:180–185. [Google Scholar]

7. Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014; 32: 1380–1389. [PMC free article] [PubMed] [Google Scholar]

8. Kahn A, Chaushu G, Ginene L, Vered M. Age and Expression of CD163 and Colony-Stimulating Factor 1Receptor (CD115) Are Associated with the Biological Behavior of Central Giant Cell Granuloma. J Oral Maxillofac Surg. 2017; 75: 1414–1424. [PubMed] [Google Scholar]

9. Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, et al. Serum microRNA expression profile: miR-1246 as a noveldiagnostic and prognostic biomarker for oesophageal squamouscell carcinoma. Br J Cancer. 2013; 108: 644–652. [PMC free article] [PubMed] [Google Scholar]

10. Chaparro-Avendaño AV, Berini-Aytés L, Gay-Escoda C. Peripheral giant cell granuloma. A report of five cases and review of the literature. Med Oral Patol Oral Cir Bucal. 2005; 10: 48–57. [PubMed] [Google Scholar]

11. Motamedi MH, Eshghyar N, Jafari SM, Lassemi E, Navi F, Abbas FM, et al. Peripheral and central giant cell granulomas of the jaws: a demographic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103: e39–e43. [PubMed] [Google Scholar]

12. Peacock ZS, Jordan RC, Schmidt BL. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior? J Oral Maxillofac Surg. 2012; 70: 1860–1866. [PubMed] [Google Scholar]

13. Dewsnup NC, Susarla SM, Abulikemu M, Faquin WC, Kaban LB, August M. Immunohisto-chemical evaluation of giant cell tumors of the jawsusing CD34 density analysis. J Oral Maxillofac Surg. 2008; 66: 928–933. [PubMed] [Google Scholar]

14. Hallikeri K, Acharya S, Koneru A, Trivedi DJ. Evaluation of microvessel density in central and peripheral giant cell granulomas. J Adv Clin Res Insights. 2015; 2: 20–25. [Google Scholar]

15. Tobón-Arroyave SI, Hurtado-García P, García-Quintero OD, Isaza-Guzmán DM, Flórez-Moreno GA. Immunoexpression of NF-ĸB and their inhibitory subunits IĸBα and IĸBβ in giant cell lesions of the jaws: implications for their clinical behavior. J Oral Pathol Med. 2015; 44: 752–760. [PubMed] [Google Scholar]

16. Whitaker SB, Bouquot JE. Identification and semi-quantification of estrogen and progesterone receptors in peripheral giant cell lesions of the jaws. J Periodontol. 1994; 65: 280–283. [PubMed] [Google Scholar]

17. Nair S, Nayak R, Bhat K, Kotrashetti VS, Babji D. Immunohistochemical Expression of CD105 and TGF-β1 in OralSquamous Cell Carcinoma and Adjacent Apparently Normal OralMucosa and its Correlation with Clinicopathologic Features. Appl Immunohistochem Mol Morphol. 2016; 24: 35–41. [PubMed] [Google Scholar]

18. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006; 54: 385–395. [PubMed] [Google Scholar]

19. Torabinia N, Razavi SM, Shokrolahi Z. A comparative immunohistochemical evaluation of CD68 and TRAP protein expression in central and peripheral giant cell granulomas of the jaws. J Oral Pathol Med. 2011; 40: 334–337. [PubMed] [Google Scholar]

20. Khiavi MM, Aghbali AA, Halimi M, Kouhsoltani M, Hamishehkar H. Immunohistochemical expression of Src protein in peripheral and central giant cell granulomas of the jaws. J Oral Maxillofac Pathol. 2013; 17: 358–362. [PMC free article] [PubMed] [Google Scholar]

21. Zargaran M, Moghimbeigi A, Afsharmoghadam N, Nasr Isfahani M, Hashemi A. A Comparative Study of Cathepsin D Expression in Peripheraland Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique. J Dent (Shiraz) 2016; 17: 98–104. [PMC free article] [PubMed] [Google Scholar]

Journal of Dentistry

Expression of CD34 and CD31 in Central and Peripheral Giant Cell Granulomas

References

References

Volume 20, Issue 1 - Serial Number 1
March 2019
Pages 10-15

Expression of CD34 and CD31 in Central and Peripheral Giant Cell Granulomas

References

References

Volume 20, Issue 1 - Serial Number 1March 2019Pages 10-15

Volume 20, Issue 1 - Serial Number 1
March 2019
Pages 10-15